PSMA-PET-derived tumor volume (PSMA-TV) is an emerging imaging biomarker, with several studies proposing benefits for therapy response assessment [9–11] and for the prognostication of overall survival [10, 12]. The gene discussed is FOLH1; the disease is neoplasm.